| Mrs Katherine Hay Romp, PA-C | |
|
5308 Harroun Rd Ste 280, Sylvania, OH 43560-2190 | |
| (419) 524-5668 | |
| (419) 885-6919 |
| Full Name | Mrs Katherine Hay Romp |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 5308 Harroun Rd Ste 280, Sylvania, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083728638 | NPI | - | NPPES |
| 0071140 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Katherine Hay Romp, PA-C 5308 Harroun Rd Ste 280, Sylvania, OH 43560-2190 Ph: (419) 885-6919 | Mrs Katherine Hay Romp, PA-C 5308 Harroun Rd Ste 280, Sylvania, OH 43560-2190 Ph: (419) 524-5668 |
News Archive
Older parents frequently give help to their middle-aged offspring, and their perceptions about giving this help may affect their mental health, according to a team of researchers.
Researchers at the University of Cincinnati College of Medicine have discovered a new potential strategy to personalize therapy for brain and blood cancers.
In a systematic review published by the Cochrane Collaboration last week, researchers found that the micronutrient powder used in recent years to combat malnutrition, anemia and iron deficiency in children was very helpful in preventing malnutrition in children six to 24 months old, VOA News reports.
Combining the therapeutic potential and advantages of existing oligonucleotide-based approaches to turn off disease-related genes, a type of single-stranded silencing RNAs (ss-siRNAs) has shown significantly improved potency and activity.
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.
› Verified 4 days ago
Rebecca M. Burgoon, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5700 Monroe St Unit 103, Sylvania, OH 43560 Phone: 419-843-7996 Fax: 419-841-7704 | |
Ryan Joseph Szenderski, P A Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7640 Sylvania Avenue, # 100, Sylvania, OH 43560 Phone: 419-473-2273 Fax: 419-473-0474 | |
Jenna Yeager, PA-C, ATC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7640 Sylvania Ave Ste B, Sylvania, OH 43560 Phone: 419-517-8178 Fax: 419-517-8188 | |
Kathleen M Hoitenga, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5700 Monroe St Unit 101, Sylvania, OH 43560 Phone: 419-291-6777 Fax: 419-480-6607 | |
Tayler Lauren Pilmore, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5308 Harroun Rd # 285, Sylvania, OH 43560 Phone: 419-824-1785 Fax: 419-824-5953 | |
Lauren G Pakosz, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5700 Monroe St Unit 111, Sylvania, OH 43560 Phone: 567-585-0005 Fax: 567-585-0007 |